3IPU image
Deposition Date 2009-08-18
Release Date 2010-06-02
Last Version Date 2024-04-03
Entry Detail
PDB ID:
3IPU
Keywords:
Title:
X-ray structure of benzisoxazole urea synthetic agonist bound to the LXR-alpha
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
(Taxon ID: )
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.40 Å
R-Value Free:
0.29
R-Value Work:
0.23
R-Value Observed:
0.23
Space Group:
P 4 21 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Oxysterols receptor LXR-alpha
Gene (Uniprot):NR1H3
Chain IDs:A, B
Chain Length:283
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Nuclear receptor coactivator 1
Gene (Uniprot):NCOA1
Chain IDs:C, D
Chain Length:25
Number of Molecules:2
Biological Source:
Primary Citation
X-ray structures of the LXRalpha LBD in its homodimeric form and implications for heterodimer signaling.
J.Mol.Biol. 399 120 132 (2010)
PMID: 20382159 DOI: 10.1016/j.jmb.2010.04.005

Abstact

Liver X receptors (LXRs) are nuclear receptors that are central regulators of cholesterol homeostasis, and synthetic LXR agonists have shown promise as promoters of reverse cholesterol transport and anti-inflammatory agents. Here, we present three X-ray structures of three different agonists bound to the ligand binding domain of LXRalpha. These compounds are GW3965, F(3)methylAA, and a benzisoxazole urea, and we show that these diverse chemical scaffolds address common structural themes, leading to high binding affinity for LXR. Our structures show the LXRalpha ligand binding domain in its homodimeric form, an arrangement previously thought to be stereochemically difficult. A comparison with existing structures of the LXRbeta homodimer and LXRalpha:RXR (retinoid X receptor) heterodimers explains differences in dimer affinity and leads us to propose a model for allosteric activation in nuclear receptor dimers, in which an unactivated RXR partner provides an inhibitory tail wrap to the cofactor binding pocket of LXR.

Legend

Protein

Chemical

Disease

Primary Citation of related structures